DR-TB Drugs Under the Microscope
This report analyses the factors affecting access to treatment regimens for drug-resistant tuberculosis (DR-TB), including new and repurposed drugs. Detailed pricing profiles of key DR-TB drugs are also provided.
Author:
Doctors Without Borders/Medecins Sans Frontieres
Audiences:
International Agencies, Policy Makers
Topic:
Extensively Drug-Resistant TB (XDR TB), MDR TB, TB Treatment, Treatment- Medication Information, Treatment- TB Disease
Global resources for the prevention,
management, and elimination of TB.